Cargando…
Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
Psoriasis is a chronic immune-mediated disease involving complex interaction of T cells and keratinocytes. The comprehensive pathogenesis of psoriasis is not fully understood but the IL-23/Th17 axis is a central pathway in driving disease development. Guselkumab is the first treatment of moderate-to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815086/ https://www.ncbi.nlm.nih.gov/pubmed/33488109 http://dx.doi.org/10.2147/CCID.S235242 |